It is of great interest to understand insulin and glucose regulation in normal or disease states, which may help discovering therapeutic agents that enhance insulin release from the dormant islets in the setting of type 2 diabetes mellitus. The gene discussed is INS; the disease is type 2 diabetes mellitus.